SCHEMBL10144893

SCHEMBL10144893

COc1ccc2oc(/C=C/c3ccc(N)cc3)cc(=O)c2c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.78
MAOB P27338 2/20 0.78
MAPT P10636 6/20 0.70
APP P05067 6/20 0.70
KDM4E B2RXH2 5/20 0.70
ALDH1A1 P00352 5/20 0.70
HPGD P15428 5/20 0.70
STS P08842 1/20 0.58
SMN1; SMN2 Q16637 4/20 0.52
TP53 P04637 2/20 0.52
HSD17B10 Q99714 2/20 0.52
CASP1 P29466 1/20 0.52
CASP7 P55210 1/20 0.52
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
LMNA P02545 1/20 0.50
CYP3A4 P08684 1/20 0.50
THRB P10828 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4992744 1.00 MAOA (0.78) MAOAMAOBMAPTAPPKDM4E
SCHEMBL10144902 0.85 MAOA (0.74) MAOAMAOBMAPTAPPKDM4E
SCHEMBL4987371 0.85 MAOA (0.74) MAOAMAOBMAPTAPPKDM4E
SCHEMBL10144898 0.85 MAOA (0.74) MAOAMAOBMAPTAPPKDM4E
SCHEMBL4983225 0.85 MAOA (0.74) MAOAMAOBMAPTAPPKDM4E
SCHEMBL11729545 0.84 MAOA (0.73) MAOAMAOBMAPTAPPKDM4E
SCHEMBL11734058 0.84 MAOA (0.73) MAOAMAOBMAPTAPPKDM4E
SCHEMBL9976051 0.84 MAOA (0.73) MAOAMAOBMAPTAPPKDM4E
SCHEMBL11734061 0.84 MAOA (0.73) MAOAMAOBMAPTAPPKDM4E
SCHEMBL11729537 0.84 MAOA (0.73) MAOAMAOBMAPTAPPKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8192717-B2 Flavone derivative, chalcone derivative, styrylchromone derivative, or a coumarin derivative with high binding specificity to an amyloid beta protein, high permeability to a blood-brain barrier, and ability to rapidly disappear from sites other than cerebral senile plaque; also drug screening NAGASAKI UNIVERSITY (JP) 2012-06-05 US disclosed
US-20080131367-A1 Composition For Diagnosing Amyloid-Related Diseases Mori, Hiroshi (JP) 2008-06-05 US disclosed
EP-1815872-A1 COMPOSITION FOR AMYLOID-ASSOCIATED DISEASE DIAGNOSIS Nagasaki University (JP) 2007-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080131367-A1 Composition For Diagnosing Amyloid-Related Diseases APP, APBA1, FABP7 MAOA 2873/4885MAOB 2191/4885MAPT 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.